Evaluation of Systematic Intravenous Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced.
Inclusion Criteria:
- Age ≥ 18 years
- Well-informed written consent, signed by the patient
- Patient picked up for solid tumor treatment, whichever the localization, with or
without metastasis
- Patient revealing, before or during chemotherapy, a moderate anemia, that means: Men:
9
- Patient for who at least four chemotherapy cycles are planed (eight in case of weekly
chemotherapy) after inclusion in the study
- Patients with life expectancy higher than three months
- Patient with general conditions compatible with the study's follow-up
Exclusion Criteria:
- Contra-indication for Venofer
- Anemia which can have curative treatment
- Bloody transfusion during the previous four weeks
- Documented or suspected medullary invasion
- Uncontrolled arterial hypertension
- Acute bacterial infection
- Transferrin saturation's coefficient
- Pregnancy
- Ferric salts oral treatment interrupted since less than one week
- Patient with bad french language's comprehension
- Patient with a major psychiatric pathology
- Patient under guardianship, trusteeship or justice safeguard